Navigation Links
Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results
Date:11/1/2011

study published in the August 2011 issue of the journal Gastroenterology showed that LX1031 was well tolerated and provided clinical benefit to patients with non-constipating IBS, showing improvements in a global assessment of adequate relief from IBS pain and discomfort and in stool consistency, with symptom relief correlating with reductions in the 5-HIAA biomarker.  Like LX1031, LX1033 acts locally in the gastrointestinal tract to reduce serotonin production by inhibiting tryptophan hydroxylase, a key enzyme in the biosynthesis of serotonin.  
  • LX2931:  Lexicon initiated a dose-ranging study to explore higher doses of LX2931 in rheumatoid arthritis patients.  Previously-reported Phase 2a results of LX2931, an inhibitor of sphingosine-1-phosphate lyase, demonstrated a favorable safety profile at all doses tested and suggest that rheumatoid arthritis patients treated with 150 mg of LX2931 once daily showed improvement in the primary efficacy endpoint of the study, the percentage of patients achieving an American College of Rheumatology 20 (ACR20) response at week 12.

  • Financial Results Revenues:  Lexicon's revenues for the three months ended September 30, 2011 decreased 55 percent to $0.4 million from $0.8 million for the corresponding period in 2010.  For the nine months ended September 30, 2011, revenues decreased 59 percent to $1.5 million from $3.7 million for the corresponding period in 2010.

    Research and Development Expenses:  Research and development expenses for the three months ended September 30, 2011 increased 4 percent to $19.7 million from $18.9 million for the corresponding period in 2010, primarily due to an increase in external preclinical and clinical research and development costs, offset by a decrease in personnel costs.  For the nine months ended September 30, 2011, research and develop
    '/>"/>

    SOURCE Lexicon Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2011 Financial Results
    2. Lexicon Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual Meeting
    3. Lexicon Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
    4. Lexicon Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
    5. Lexicon Pharmaceuticals to Present at the Wedbush 2011 Life Sciences Management Access Conference
    6. Lexicon Announces Publication of Results From the Phase 2 Trial of LX1031 in Patients With Irritable Bowel Syndrome in Journal of Gastroenterology
    7. Phase 2 Trial of Lexicons LX1032, Telotristat Etiprate, Shows Positive Results in Carcinoid Syndrome
    8. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Second Quarter Results
    9. Lexicons IBS Drug Candidate, LX1033, Successfully Completes Phase 1 Clinical Trial
    10. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
    11. Lexicon Pharmaceuticals Announces Webcast of 2011 Annual R&D Day
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/24/2015)... 24, 2015   Bernstein Liebhard LLP ... or the "Company") (NASDAQ: AERI ) issued ... violation of the federal securities laws; or (ii) ... fiduciary duties to shareholders. Aerie is ... development and commercialization of first-in-class therapies for the ...
    (Date:4/24/2015)... April 24, 2015 Allowing more basic emergency ... drug overdose deaths that involve opioids, according to a ... in Naloxone Administration by Emergency Medical Service Providers and ... in the American Journal of Public Health . ... the United States involved prescription ...
    (Date:4/24/2015)... April 24, 2015  A new study shows an "alarming ... drugs used to slow the progression of multiple sclerosis or ... by researchers at Oregon Health & Science University (OHSU) and ... the number of MS drugs in the marketplace over the ... stabilized costs for patients who use those drugs. Researchers found ...
    Breaking Medicine Technology:Bernstein Liebhard LLP Investigates Claims On Behalf Of Those Who Invested In Aerie Pharmaceuticals, Inc. 2Expanding Naloxone use could reduce drug overdose deaths and save lives 2Expanding Naloxone use could reduce drug overdose deaths and save lives 3Researchers find alarming rise in cost of MS drugs over past two decades 2Researchers find alarming rise in cost of MS drugs over past two decades 3Researchers find alarming rise in cost of MS drugs over past two decades 4
    ... 2007 - BioLineRx Ltd.,(TASE:BLRX), Israel's leading drug ... I trial of BL-1020, the first GABA,enhanced ... The trial demonstrated that the compound was ... which is indicative of efficacy. BioLineRx presented ...
    ... -- Auxilium,Pharmaceuticals, Inc. today announced that new ... energy levels and,erectile function in 76 percent ... replacement gel therapy. Total testosterone,levels increased significantly ... (testosterone gel) following suboptimal,response to Solvay S.A.'s ...
    Cached Medicine Technology:BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 2BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 3BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 4Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 2Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 3Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 4Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 5
    (Date:4/24/2015)... 2015 Bird B Gone, the leader in ... offers a complete line of bird control solutions to address ... New Flu Strains Threaten Pacific, Central and Mississippi Farms , ... , a number of highly pathogenic avian flus in the ... often spread when wild birds enter poultry farms. The USDA ...
    (Date:4/24/2015)... Ranch, California (PRWEB) April 24, 2015 ... has a wide range of capabilities and services to ... , Ryadon's Quantity Discount Program will be offered ... as follows: , Order 4-19: Receive 10% discount - ... Benefit by Using the Drawer Slides Products, ...
    (Date:4/24/2015)... (PRWEB) April 24, 2015 The 1975 ... toured almost constantly across the globe to theaters, festivals and ... in Manchester, they’ve partnered with their label, Dirty Hit Records, ... Teaming up with the newly launched Cadence & Cause ... their debut LP on vinyl and a signed photo card. ...
    (Date:4/24/2015)... Carinsurancequotesinfo.com has released a new blog post has ... qualify for auto insurance as a single parent. ... online, without having to follow a special process. The ... reduce their auto insurance expenses. The tips are presented ... , Clients can now visit an insurance brokerage website ...
    (Date:4/24/2015)... “Kind,” “selfless,” “the voice of reason” and “truly ... described pediatric oncology nurse Laura Vasquez of Children’s Hospital ... her five-year battle with a malignant brain tumor. Through ... numerous experimental treatments, Vasquez continued caring for Alexa, stopping ... not in the hospital and even sitting vigil during ...
    Breaking Medicine News(10 mins):Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 2Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 4Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 3Health News:Internationally Recognized British Indie Rock Outfit The 1975 Partner with Cadence & Cause to Provide Clean Drinking Water to Those in Need 2Health News:Auto Insurance Discounts for Single Parents - How to Qualify for Low Rates 2Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 2Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 3Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 4
    ... Quantum Group,Inc. (NYSE Alternext US: QGP) ( www.QuantumMD.com ... today that it supports the American,Recovery and Reinvestment ... The Quantum Group President ... few weeks Congress will be considering the American ...
    ... SAN DIEGO, Jan. 20 BioMed Realty Trust, Inc. (NYSE: BMR ) today announced the tax treatment of its 2008 distributions as follows:, ... CUSIP: 09063H107, ... ... Record Payable Distribution Allocable Ordinary, ...
    ... still entitled to before you leave can save you money, improve your ... ... -- Each year, millions of Americans are diagnosed with permanent or long-term ... Too often, however, people simply quit their jobs without knowing their rights, ...
    ... ... Wayne, New Jersey (PRWEB) January 20, 2009 ... record increases in new accounts and overall usage of it,s automated ... given more companies more reason to look for cost cutting measures. ...
    ... hearing system uses innovative technology to improve speech ... Phonak, the world,s leading manufacturer of ... Audeo YES, people with hearing loss are once ... life as the world,s smallest completely wireless hearing ...
    ... as RECIST, used by clinicians to measure tumour size ... 20 January) in a special issue of the European ... revisions will ease the workload involved in running clinical ... Criteria in Solid Tumours) were first published in 2000 ...
    Cached Medicine News:Health News:The Quantum Group Announces Support of Technology Bill Before Congress 2Health News:The Quantum Group Announces Support of Technology Bill Before Congress 3Health News:The Quantum Group Announces Support of Technology Bill Before Congress 4Health News:BioMed Realty Trust Announces Tax Treatment of 2008 Distributions 2Health News:BioMed Realty Trust Announces Tax Treatment of 2008 Distributions 3Health News:Allsup Outlines Rights of People Leaving Work Due to a Disability 2Health News:Allsup Outlines Rights of People Leaving Work Due to a Disability 3Health News:Allsup Outlines Rights of People Leaving Work Due to a Disability 4Health News:Allsup Outlines Rights of People Leaving Work Due to a Disability 5Health News:Allsup Outlines Rights of People Leaving Work Due to a Disability 6Health News:Conf$ave Announces Record Growth By Providing Substantial Savings To Customers 2Health News:Enjoy the Full Sound Spectrum in a Stylish Way, with Audeo YES 2Health News:Enjoy the Full Sound Spectrum in a Stylish Way, with Audeo YES 3Health News:New criteria for measuring tumor size and progression will help ease workloads in clinical trials 2Health News:New criteria for measuring tumor size and progression will help ease workloads in clinical trials 3Health News:New criteria for measuring tumor size and progression will help ease workloads in clinical trials 4
    The Simpulse Solo Pulsed Lavage System requires minimal set up and has a Wide range of tips available for every orthopaedic procedure. It uses a separate suction lumen to reduce clogging and n ergono...
    Used for arthroscopic or open shoulder surgery. Powered positioning of back section inclines from 0 degrees to 90 degrees. Removable shoulder panels provide an eight-inch (203-mm) access area behind ...
    ... important part in our daily lives. But ... can cause severe handicaps. A decisive consideration ... was to produce a reconstructed joint function ... nearly possible.,The cementless RM Finger System has ...
    ... The hands play an important part in ... impairments and rheumatic changes can cause severe ... of the finger-joint prostheses was to produce ... the natural function as nearly possible.,The cementless ...
    Medicine Products: